BURZYNSKI RESEARCH INSTITUTE INC
BZYR · In Vitro and in Vivo Diagnostic Substances
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q4 2025
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Szopa-Paszkowiak Monika: Form 3
Insider disclosure · Filed · Report period 06 Oct 2021
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- BZYR · 123159105 - COM
Company details and SEC sources
CIK 0000724445 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- BZYR on OTC
- SEC industry group
- In Vitro and in Vivo Diagnostic Substances (Office of Life Sciences)
- Business address
- 12000 Richmond Ave, Houston, TX, 77082
- Incorporated in
- DE
- Fiscal year end
- 28 February
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields